financetom
Business
financetom
/
Business
/
Millicom Stock Gains As Xavier Niel Reportedly Boosts Bid To $4.4B; Quarterly Earnings Miss Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Millicom Stock Gains As Xavier Niel Reportedly Boosts Bid To $4.4B; Quarterly Earnings Miss Estimates
Aug 2, 2024 9:24 AM

Millicom International Cellular S.A. ( TIGO ) shares are trading higher on Friday.

Billionaire Xavier Niel reportedly increased his bid for Millicom International to approximately $4.4 billion after the Latin American phone carrier rejected an earlier offer as insufficient.

Niel’s Atlas Luxco Sarl has now proposed $25.75 per share in cash, up from the previous $24 per share, reported BNN Bloomberg.

Millicom’s independent board committee had previously rejected this bid, with Atlas initially arguing that there were no new reasons justifying a higher price.

Meanwhile, the company reported quarterly earnings per share of 46 cents, missing the street view of 54 cents. Quarterly sales of $1.458 billion missed the analyst consensus of $1.483 billion.

Also Read: Emerging Tesla Rival Vinfast Launches Affordable Mini E-SUV In Vietnam, Aims To Deliver 20K Units In 2024

“Millicom has undergone an important transformation aimed at significantly increasing the company’s equity free cash flow generation. These efforts began to pay off in Q2, with EBITDA up almost 20% organically, EFCF of $268 million and leverage down significantly to 2.77x, putting the company on track to achieve its 2024 targets,” said  Chief Executive Officer Marcelo Benitez.

The company said it is prioritizing ARPU growth in Mobile, reducing churn in Home, and accelerating growth in B2B.

The company is also making return-focused investments to sustain market position and drive customer growth in the second half of 2024. All these actions are designed to ensure continued EFCF growth in 2025 and beyond, in line with the long-term plan, Millicom said.

Millicom targets equity-free cash flow above $600 million in 2024, excluding proceeds for the previously-announced tower sale in Colombia. Millicom also targets leverage to near 2.5x at year-end 2024.

Price Action: TIGO shares are trading higher by 5.81% to $26.04 at last check Friday.

Image generated using DALL-E.

Read Next:

Tesla Engineer Showcases First Cybertruck With Dry Cathode 4680 Cells Aimed At Reducing Costs

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Westinghouse Air Brake Technologies Insider Sold Shares Worth $487,010, According to a Recent SEC Filing
Westinghouse Air Brake Technologies Insider Sold Shares Worth $487,010, According to a Recent SEC Filing
Apr 29, 2024
10:01 AM EDT, 04/29/2024 (MT Newswires) -- David L DeNinno, Executive Vice President, General Counsel and Secretary, on April 25, 2024, sold 3,016 shares in Westinghouse Air Brake Technologies ( WAB ) for $487,010. Following the Form 4 filing with the SEC, DeNinno has control over a total of 65,352 shares of the company, with 65,352 shares held directly. SEC...
Allegiant Travel Reports Decrease in March, Q1 Passenger Count
Allegiant Travel Reports Decrease in March, Q1 Passenger Count
Apr 29, 2024
09:54 AM EDT, 04/29/2024 (MT Newswires) -- Allegiant Travel Company ( ALGT ) said Monday that its preliminary total system passenger count in March dropped 1.3% year over year to about 1.67 million. Available seat miles last month rose 2.2% from a year earlier, while departures rose 0.2%, the travel company said. In Q1, the company's total system passenger count...
GE HealthCare Technologies Receives FDA Marketing Clearance for Portrait VSM Monitor
GE HealthCare Technologies Receives FDA Marketing Clearance for Portrait VSM Monitor
Apr 29, 2024
10:00 AM EDT, 04/29/2024 (MT Newswires) -- GE HealthCare Technologies ( GEHC ) said Monday that it has received 510(k) clearance from the US Food and Drug Administration for its Portrait VSM vital signs monitor. The device uses a non-invasive blood pressure algorithm to provide measurement readings for blood pressure, pulse rate, oxygen saturation, body temperature and respiratory rate. A...
US FDA publishes final rule for laboratory developed tests
US FDA publishes final rule for laboratory developed tests
Apr 29, 2024
April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved